RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Piletz to Adrenergic alpha-Antagonists

This is a "connection" page, showing publications John Piletz has written about Adrenergic alpha-Antagonists.
Connection Strength

0.379
  1. Piletz JE, Segraves KB, Feng YZ, Maguire E, Dunger B, Halaris A. Plasma MHPG response to yohimbine treatment in women with hypoactive sexual desire. J Sex Marital Ther. 1998 Jan-Mar; 24(1):43-54.
    View in: PubMed
    Score: 0.155
  2. Piletz JE, Halaris A, Saran A, Marler M. Elevated 3H-para-aminoclonidine binding to platelet purified plasma membranes from depressed patients. Neuropsychopharmacology. 1990 Jun; 3(3):201-10.
    View in: PubMed
    Score: 0.092
  3. Zhu H, Halaris A, Piletz JE. Atypical [(3)H]clonidine binding sites in human caudate and platelets on cryostat-cut sections. Ann N Y Acad Sci. 2003 Dec; 1009:296-301.
    View in: PubMed
    Score: 0.059
  4. Zhu H, Paul IA, Stec DE, Peeler DF, Piletz JE. Non-adrenergic exploratory behavior induced by moxonidine at mildly hypotensive doses. Brain Res. 2003 Feb 21; 964(1):9-20.
    View in: PubMed
    Score: 0.055
  5. Piletz JE, Schubert DS, Halaris A. Evaluation of studies on platelet alpha 2 adrenoreceptors in depressive illness. Life Sci. 1986 Nov 03; 39(18):1589-616.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support